Enniatin B alters bovine polymorphonuclear leukocytes phagocytosis and extracellular reactive oxygen species production in vitro
View abstract on PubMed
Summary
This summary is machine-generated.Enniatin B (ENN B), a common mycotoxin, did not harm bovine immune cells but impaired their ability to fight bacteria and increased harmful reactive oxygen species (ROS). This suggests ENN B may weaken the bovine immune response, increasing infection risk.
Area Of Science
- Veterinary Immunology
- Mycotoxicology
- Cellular Immunology
Background
- Enniatins (ENNs) are mycotoxins affecting animal health, with Enniatin B (ENN B) being frequently detected in food and feed.
- Bovine polymorphonuclear leukocytes (PMNs) are crucial for innate immunity, defending against pathogens.
Purpose Of The Study
- To investigate the in vitro effects of Enniatin B on the function of bovine polymorphonuclear leukocytes (PMNs).
- To assess Enniatin B's impact on PMN viability, chemotaxis, phagocytosis, and extracellular reactive oxygen species (ROS) production.
Main Methods
- Bovine PMNs were isolated and exposed to varying concentrations of Enniatin B (0.625–10 μM).
- Cell viability, chemotactic activity, phagocytosis of E. coli and S. aureus, and extracellular ROS production were measured.
- Experiments were conducted under both physiological and pro-inflammatory (PMA-stimulated) conditions.
Main Results
- Enniatin B did not affect bovine PMN viability or chemotactic activity across all tested concentrations.
- Phagocytosis of Gram-positive (S. aureus) and Gram-negative (E. coli) bacteria was significantly reduced by higher Enniatin B concentrations (5 and 10 μM).
- Extracellular ROS production was notably increased by Enniatin B under both physiological and pro-inflammatory conditions.
Conclusions
- Enniatin B exhibits immunomodulatory effects on bovine PMNs in vitro, without causing direct cytotoxicity.
- The observed reduction in phagocytosis and increase in ROS suggest Enniatin B may compromise the bovine innate immune response.
- These findings highlight a potential risk for increased susceptibility to infections in animals exposed to Enniatin B.

